What is it about?
This study focuses on the synthetic strategies for current developments of 1,3,5-triazine-based anticancer agents and discuses the docking studies that confirm their unique binding modes in the targeted receptors active sites.
Featured Image
Why is it important?
This article also aims to highlight the future directions for the easy access to 1,3,5-triazine-based frameworks of more potent and specific anticancer activity.
Perspectives
The use of the available data of the biological targets in this article will allow the researchers to develop new drugs directed to selected targets, thus producing more potent anticancer agents of least drawbacks.
manal anwar
National Research Centre/Cairo/ Egypt
Read the Original
This page is a summary of: Development, potential anticancer activity and the receptor Profile of different functionalized 1,3,5-Triazine derivatives, Mini-Reviews in Medicinal Chemistry, September 2017, Bentham Science Publishers,
DOI: 10.2174/1389557517666170927160256.
You can read the full text:
Contributors
The following have contributed to this page
